Prostate Cancer - Results from #1120

Beyond the Abstract - Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden, by Benny Holmström, et al. July 11, 2011

Beyond the Abstract - Efficacy and safety of dutasteride on prostate cancer risk reduction in Asian men: The results from the REDUCE study, by Hideyuki Akaza, MD July 4, 2011

Beyond the Abstract - Regression of prostate tumors upon combination of hormone ablation therapy and Celecoxib in vivo, by Per Borgström, PhD, et al. July 1, 2011

Beyond the Abstract - Endoglin suppresses human prostate cancer metastasis, by Michael Breen, MD, PhD Candidate and Raymond Bergan, MD June 28, 2011

Beyond the Abstract - Adjuvant medical therapy for prostate cancer, by Thomas W. Flaig, MD June 24, 2011

Beyond the Abstract - Does valproic acid induce neuroendocrine differentiation in prostate cancer? by Abhinav Sidana, MD June 23, 2011

Beyond the Abstract - Synthesis and biological analysis of prostate-specific membrane antigen-targeted anticancer prodrugs, by Sumith A. Kularatne, PhD and Philip S. Low, PhD June 16, 2011

Beyond the Abstract - Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer, by George E. Sandusky, DVM, PhD June 6, 2011

Beyond the Abstract - Does the criterion for prostate biopsy indication impact its accuracy? A prospective population-based outpatient clinical setting study, by Leonardo Oliveira Reis, MD, MSc May 26, 2011

Beyond the Abstract - A prospective, randomized trial comparing the Vienna nomogram to an eight-core prostate biopsy protocol, by Angus Lecuona, and Chris F. Heyns May 26, 2011

Beyond the Abstract - ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program, by Sumit Isharwal, MD and Robert W. Veltri, PhD May 25, 2011

Beyond the Abstract - Prostate cancer in men 70 years old or older, indolent or aggressive: Clinicopathological analysis and outcomes, by Stephen A. Brassell, MD, FACS May 24, 2011

Beyond the Abstract - Clinical map document based on XML (cMDX): Document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens, by Okyaz Eminaga, MD April 19, 2011

Beyond the Abstract - American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the transperineal permanent brachytherapy of prostate cancer, by Seth A. Rosenthal, MD, FACR April 18, 2011

Beyond the Abstract - Could prostate biopsies be avoided in men older than 75 years with raised PSA? by Michael Nomikos, MD, FEBU April 18, 2011

Beyond the Abstract - Diffusion weighted imaging in prostate cancer, by Cher Heng Tan, MD April 15, 2011

Beyond the Abstract - Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome, by Luis Menéndez-Arias April 14, 2011

Beyond the Abstract - Vitamin D and prostate cancer: The role of membrane initiated signaling pathways in prostate cancer progression, by Sandra Karlsson, et al April 13, 2011

Beyond the Abstract - Successful implementation of image-guided radiation therapy quality assurance in the Trans Tasman Radiation Oncology Group 08.01 PROFIT Study, by Mark Middleton, B.App.Sc., Grad. Dip. VET, MBA, FIR April 12, 2011

Beyond the Abstract - Low dose of ketoconazole in patients with prostate adenocarcinoma resistant to pharmacological castration, by Roberto Iacovelli, MD, et al April 11, 2011

Page 57 of 58